Get all your news in one place.

100’s of premium titles.
One app.

Get all your news in one place.

100’s of premium titles. One news app.

The Latest Breaking News from DocuSign

Why This Analyst Is Bullish On Tech, But Bearish On DocuSign

DocuSign Inc (NASDAQ: DOCU) is among the “have nots” in the tech sector and may continue to see its multiplies compress “as results soften off pandemic highs,” according to Wedbush.

Benzinga

Analyst Ratings for DocuSign

Over the past 3 months, 14 analysts have published their opinion on DocuSign (NASDAQ:DOCU) stock. These analysts are typically employed by large Wall Street banks and tasked with understanding a company's business to predict how a stock will trade over the upcoming year.

Benzinga

Zoom Video vs. DocuSign: Which Tech Stock Is a Better Buy the Dip Candidate?

StockNews.com

From analysis to the latest developments in health,
read the most diverse news in one place.

Benzinga's Top Ratings Upgrades, Downgrades For May 3, 2022

Upgrades

Benzinga

Expert Ratings For DocuSign

Within the last quarter, DocuSign (NASDAQ:DOCU) has observed the following analyst ratings:

Benzinga

This Is What Whales Are Betting On DocuSign

Someone with a lot of money to spend has taken a bullish stance on DocuSign (NASDAQ:DOCU). And retail traders should know. We noticed this today when the big position showed up on publicly available options history that we track here at Benzinga.

Benzinga

DocuSign Whale Trades For March 30

A whale with a lot of money to spend has taken a noticeably bearish stance on DocuSign. Looking at options history for DocuSign (NASDAQ:DOCU) we detected 12 strange trades.

Benzinga

Read news from The Economist, FT, and more,
with one subscription

2 Tech Stocks to Buy During the Tech Stock Correction

Pure Storage (PSTG) and DocuSign (DOCU) have little in common from a technical standpoint, with one name recently making new multi-year lows and the other racing towards new all-time highs. However, both companies boast strong sales growth and steady earnings growth from a fundamental standpoint, and are leaders in their…

StockNews.com

Executives Buy Around $22M Of 4 Stocks

Although US stock futures traded lower this morning on Friday, there were a few notable insider trades.

Benzinga

DocuSign Whale Trades Spotted

A whale with a lot of money to spend has taken a noticeably bullish stance on DocuSign. Looking at options history for DocuSign (NASDAQ:DOCU) we detected 25 strange trades.

Benzinga

Stock Market Mostly Lower; U.S. Announces Plans To Revoke Russia's Trade Status

The stock market traded mixed as Russia indicated progress was made toward a settlement; the U.S. plans to revoke Russia's trade status.

Investors Business Daily

Benzinga's Top Ratings Upgrades, Downgrades For March 11, 2022

Upgrades

Benzinga

Why DocuSign Shares Continue To Slide Today

DocuSign Inc (NASDAQ: DOCU) shares are sliding Friday morning after several analysts downgraded or lowered price targets on the stock. DocuSign shares were falling after hours Thursday following the company's financial results and weak guidance.

Benzinga

Dow Jones Futures Jump As Putin Sees 'Positive Shift' In Ukraine Talks; Rivian, DocuSign Dive

Futures jumped early Friday as Putin cited positive shifts in Russia-Ukraine talks. The market rally showed resilience Thursday.

Investors Business Daily

Get all your
news in one place.

100’s of premium titles.
One news app.

Investors Business Daily

DocuSign Stock Tumbles As Covid-Related Business Dissipates

DocuSign stock plunged after its January-quarter earnings met estimates and revenue topped views while guidance fell short.

Benzinga

DocuSign: Q4 Earnings Insights

DocuSign (NASDAQ:DOCU) reported its Q4 earnings results on Thursday, March 10, 2022 at 04:05 PM. Here's what investors need to know about the announcement. Earnings DocuSign beat estimated earnings by 2.13%, reporting an EPS of $0.48 versus an estimate of $0.47.

Benzinga

Why DocuSign Shares Are Falling After Hours

DocuSign Inc (NASDAQ: DOCU) is trading lower after the company reported fourth-quarter financial results and issued guidance below estimates.

Benzinga

Why DocuSign Shares Are Falling

Shares of companies in the broader technology sector, including Docusign Inc (NASDAQ: DOCU), are trading lower amid overall market weakness following the collapse of Russia-Ukraine ceasefire talks.

Get all your
news in one place.

100’s of premium titles.
One news app.

Benzinga

Looking At DocuSign's Recent Whale Trades

A whale with a lot of money to spend has taken a noticeably bearish stance on DocuSign. Looking at options history for DocuSign (NASDAQ:DOCU) we detected 15 strange trades.

Benzinga

Earnings Preview: DocuSign

DocuSign (NASDAQ:DOCU) is set to give its latest quarterly earnings report on Thursday, 2022-03-10. Here's what investors need to know before the announcement. Analysts estimate that DocuSign will report an earnings per share (EPS) of $0.47.

Benzinga

DocuSign Whale Trades For February 23

Someone with a lot of money to spend has taken a bearish stance on DocuSign (NASDAQ:DOCU). And retail traders should know. We noticed this today when the big position showed up on publicly available options history that we track here at Benzinga.

Benzinga

Looking At DocuSign's Recent Whale Trades

A whale with a lot of money to spend has taken a noticeably bearish stance on DocuSign. Looking at options history for DocuSign (NASDAQ:DOCU) we detected 17 strange trades.

Benzinga

DocuSign Whale Trades Spotted

StockNews.com

Is Now a Good Time to Scoop Up Shares of Beaten-Down Work-From-Home Stocks Zoom Video, Docusign, and Twilio?

The work-from-home trend caught on as the pandemic rampaged worldwide in 2020. And although the global economy has since reopened, the demand for remote work structures has remained steady. Given its numerous benefits, it seems highly likely that work-from-home is more than just a passing trend. So, we think it…

Benzinga

What Are Whales Doing With DocuSign

1 … 5 6 7 8

People

From analysis to the latest developments in health,
read the most diverse news in one place.

Organisations

Vertex Pharmaceuticals

181 stories

DocuSign

176 stories

Read news from The Economist, FT, and more,
with one subscription

Topics

Places

Fourteen days free

Download the app

One app. One membership.
100+ trusted global sources.